Sculptra™... a sculpting agent that restores volume to correct the signs of facial fat loss

Sculptra™ is a synthetic injectable material known as “poly-L-lactic acid.” Poly-L-lactic acid is a biocompatible, biodegradable material that has been widely used for many years in dissolvable stitches, soft tissue implants, and other types of implants.

Sculptra™ is approved by the US Food and Drug Administration (FDA) for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus. Until now, there were no products that had been approved by the FDA to treat facial lipoatrophy. However, that is all changing with the introduction of Sculptra™ in the United States, offering an effective option to treat the effects of lipoatrophy.

Facial fat loss, or lipoatrophy, is the loss of fat beneath the skin, which can result in sunken cheeks, indentations and hollow eyes. Sculptra™ is injected below the surface of the skin in the area of fat loss. It provides a gradual and significant increase in skin thickness, improving the appearance of folds and sunken areas. No skin testing is required.

Sculptra™ has been safely used outside the United States since 1999 in over 150,000 patients under the trade name New-Fill™. Gardner Dermatology can now offer this treatment to you.

The effects of Sculptra™ are enduring. In a clinical study, effects lasted for up to 2 years after the first treatment session in most patients. The results from Sculptra™ are not immediate; Sculptra™ provides a gradual increase in skin thickness. Touch-up treatments may be needed to maintain the desired effects. People with mild lipoatrophy will require fewer treatments than those with severe lipoatrophy.

Most patients feel comfortable going back to their normal activities after treatment, and makeup may usually be applied in only a few hours following treatment.

Call us for more information or to schedule an appointment.